How can next-generation diagnostics aid pancreatic adenocarcinoma treatment?
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
How can next-generation diagnostics aid pancreatic adenocarcinoma treatment?
Authors
Keywords
-
Journal
Future Oncology
Volume 12, Issue 5, Pages 585-588
Publisher
Future Medicine Ltd
Online
2016-02-02
DOI
10.2217/fon.15.353
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Next-Generation Companion Diagnostics: Promises, Challenges, and Solutions
- (2015) Joseph D. Khoury et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- SPARC Expression Did Not Predict Efficacy of nab-Paclitaxel plus Gemcitabine or Gemcitabine Alone for Metastatic Pancreatic Cancer in an Exploratory Analysis of the Phase III MPACT Trial
- (2015) M. Hidalgo et al. CLINICAL CANCER RESEARCH
- Acquisition of Portal Venous Circulating Tumor Cells From Patients With Pancreaticobiliary Cancers by Endoscopic Ultrasound
- (2015) Daniel V.T. Catenacci et al. GASTROENTEROLOGY
- Expansion platform type II: testing a treatment strategy
- (2015) Daniel V T Catenacci LANCET ONCOLOGY
- Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial
- (2015) Christophe Le Tourneau et al. LANCET ONCOLOGY
- Biomarkers for personalized medicine in GI cancers
- (2015) Shuang Yin Zhang et al. MOLECULAR ASPECTS OF MEDICINE
- Extremely high genetic diversity in a single tumor points to prevalence of non-Darwinian cell evolution
- (2015) Shaoping Ling et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cell-Free DNA Next-Generation Sequencing in Pancreatobiliary Carcinomas
- (2015) O. A. Zill et al. Cancer Discovery
- Oncogenic KRAS signalling in pancreatic cancer
- (2014) S Eser et al. BRITISH JOURNAL OF CANCER
- Next-generation clinical trials: Novel strategies to address the challenge of tumor molecular heterogeneity
- (2014) Daniel V.T. Catenacci Molecular Oncology
- Development of siRNA Payloads to Target KRAS-Mutant Cancer
- (2014) T. L. Yuan et al. Cancer Discovery
- Immunohistochemically Detected Expression of 3 Major Genes (CDKN2A/p16, TP53, and SMAD4/DPC4) Strongly Predicts Survival in Patients With Resectable Pancreatic Cancer
- (2013) Minoru Oshima et al. ANNALS OF SURGERY
- Cancer statistics, 2013
- (2013) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Clinical next-generation sequencing successfully applied to fine-needle aspirations of pulmonary and pancreatic neoplasms
- (2013) Geneva Young et al. CANCER CYTOPATHOLOGY
- Randomized, Multicenter, Phase II Study of CO-101 Versus Gemcitabine in Patients With Metastatic Pancreatic Ductal Adenocarcinoma: Including a Prospective Evaluation of the Role of hENT1 in Gemcitabine or CO-101 Sensitivity
- (2013) Elizabeth Poplin et al. JOURNAL OF CLINICAL ONCOLOGY
- Understanding pancreatic cancer genomes
- (2013) Mark J. Cowley et al. Journal of Hepato-Biliary-Pancreatic Sciences
- Circulating tumour cells and cell-free DNA as tools for managing breast cancer
- (2013) Leticia De Mattos-Arruda et al. Nature Reviews Clinical Oncology
- Cancer Genome Landscapes
- (2013) B. Vogelstein et al. SCIENCE
- Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes
- (2012) Andrew V. Biankin et al. NATURE
- Molecular Profiling of Cancer—The Future of Personalized Cancer Medicine: A Primer on Cancer Biology and the Tools Necessary to Bring Molecular Testing to the Clinic
- (2011) Thomas Stricker et al. SEMINARS IN ONCOLOGY
- Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
- (2008) S. Jones et al. SCIENCE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started